(ADDV-A) ADDvise Group AB A - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0001306119

ADDV-A: Medical Equipment, Laboratory Furnishings, Ventilation Systems, Orthopedic Implants

ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, South America, Asia, and internationally. The Lab business unit provides laboratory furnishings, ventilation, climate/clean rooms, and laboratory equipment to pharmaceutical and life science industries. The Healthcare business unit develops and supplies medical equipment, pharmaceuticals, and consumables in areas, such as urology, gynecology, emergency care, and surgery. In addition, it manufactures and sells surgical tables, as well as offers cables, connectors, and wires. Further, the company offers customized solutions for the rental and sale of laboratory and medical equipment for clinical studies; designs and delivers customized cleanrooms, climate rooms, laboratory furniture, air conditioning systems, ventilated protective products, and equipment; distributes medical devices, including continuous glucose monitors and insulin pumps; orthopaedic solutions, including implants, instruments, and technologies; and develops software and instruments to quantify patient mobility, pain, and muscle strength. Additionally, it distributes healthcare and industrial ultrasound devices for healthcare and industrial applications, such as NDT inspections; operates a mail-order pharmacy; develops, manufactures, and markets over-the-counter generic drugs for pain management, coughs, colds, allergies, sinus infections, and urological conditions; products and software to streamline the monitoring of vital signs in patients in long-term care and nursing homes; and develops, manufactures, and markets colorimetric CO2 indicators used in healthcare to monitor breathing in respiratory and emergency care. The company was formerly known as ADDvise Lab Solutions AB (publ). ADDvise Group AB (publ) was incorporated in 1989 and is headquartered in Stockholm, Sweden. Web URL: https://www.addvisegroup.se

Additional Sources for ADDV-A Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ADDV-A Stock Overview

Market Cap in USD 62m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Life Sciences Tools & Services
IPO / Inception

ADDV-A Stock Ratings

Growth 5y 58.7%
Fundamental 39.0%
Dividend 1.0%
Rel. Strength Industry -1808
Analysts -
Fair Price Momentum 7.51 SEK
Fair Price DCF 61.80 SEK

ADDV-A Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 1.0%

ADDV-A Growth Ratios

Growth Correlation 3m -89.8%
Growth Correlation 12m -56.7%
Growth Correlation 5y 85.3%
CAGR 5y 46.99%
CAGR/Mean DD 5y 1.16
Sharpe Ratio 12m -1.34
Alpha -78.36
Beta 0.84
Volatility 60.71%
Current Volume 12.7k
Average Volume 20d 2.5k
What is the price of ADDV-A stocks?
As of January 22, 2025, the stock is trading at SEK 7.10 with a total of 12,672 shares traded.
Over the past week, the price has changed by -4.57%, over one month by -35.75%, over three months by -50.00% and over the past year by -57.23%.
Is ADDvise Group AB A a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, ADDvise Group AB A (ST:ADDV-A) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 39.00 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADDV-A as of January 2025 is 7.51. This means that ADDV-A is currently overvalued and has a potential downside of 5.77%.
Is ADDV-A a buy, sell or hold?
ADDvise Group AB A has no consensus analysts rating.
What are the forecast for ADDV-A stock price target?
According to ValueRays Forecast Model, ADDV-A ADDvise Group AB A will be worth about 8.1 in January 2026. The stock is currently trading at 7.10. This means that the stock has a potential upside of +14.23%.
Issuer Forecast Upside
Wallstreet Target Price 15 111.3%
Analysts Target Price - -
ValueRay Target Price 8.1 14.2%